Omniab Inc (OABI)

$1.95 -0.02 (-1.02%)
Market Cap 280.71M
Revenue (ttm) 26.39M
Net Income (ttm) -62.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -235.05%
Debt to Equity Ratio 0.00
Volume 455,000
Avg Vol 553,188
Day's Range N/A - N/A
Shares Out 143.96M
Stochastic %K 74%
Beta 0.13
Analysts Strong Sell
Price Target $7.33

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, EmeryVille, United States
JoeDeMencia
JoeDeMencia Dec. 5 at 2:33 PM
$OABI is this another bull trap or does it have some legs finally?
0 · Reply
bearsoil
bearsoil Dec. 4 at 9:08 PM
$OABI nice trading at the close Great chart Good year ahead
0 · Reply
MrEsKurr
MrEsKurr Dec. 3 at 9:33 PM
$OABI im only it at 1.86 closing price .. this also looks great.
0 · Reply
PlannedTrading101
PlannedTrading101 Nov. 24 at 4:22 PM
$OABI Looking solid!
0 · Reply
stockanalysis_
stockanalysis_ Nov. 24 at 1:16 PM
Premarket Losers: $CLSD $TWNP $PMN $SHPH $OABI Bookmark this page: https://stockanalysis.com/markets/premarket/losers/?ref=saveontrading
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:39 PM
$OABI $OBIO $OCGN 🔥
0 · Reply
Landomos
Landomos Nov. 21 at 8:13 PM
$OABI Starting to gently edge up. $4:00 would not be far fetched soon.
0 · Reply
PlannedTrading101
PlannedTrading101 Nov. 21 at 5:45 PM
$OABI 2+ coming any day IMO
0 · Reply
PlannedTrading101
PlannedTrading101 Nov. 20 at 9:10 PM
$OABI Ready to run!
0 · Reply
Stockboi_
Stockboi_ Nov. 20 at 4:03 PM
$OABI we poppin
0 · Reply
Latest News on OABI
OmniAb to Hold OmniUltra Virtual Investor Event on December 15

Dec 4, 2025, 4:05 PM EST - 3 days ago

OmniAb to Hold OmniUltra Virtual Investor Event on December 15

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

Nov 17, 2025, 5:23 PM EST - 20 days ago

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

OmniAb, Inc. (OABI) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 11:46 PM EST - 4 weeks ago

OmniAb, Inc. (OABI) Q3 2025 Earnings Call Transcript

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Nov 4, 2025, 4:05 PM EST - 4 weeks ago

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

OmniAb to Participate in Three Investor Conferences in November

Oct 16, 2025, 8:00 AM EDT - 7 weeks ago

OmniAb to Participate in Three Investor Conferences in November

OmniAb to Report Third Quarter 2025 Financial Results on November 4

Oct 14, 2025, 8:00 AM EDT - 7 weeks ago

OmniAb to Report Third Quarter 2025 Financial Results on November 4

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:00 AM EDT - 3 months ago

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Top 3 Health Care Stocks You'll Regret Missing This Quarter

Aug 26, 2025, 7:12 AM EDT - 3 months ago

Top 3 Health Care Stocks You'll Regret Missing This Quarter

NNOX ZTEK

OmniAb Announces $30 Million Private Placement

Aug 25, 2025, 7:00 AM EDT - 3 months ago

OmniAb Announces $30 Million Private Placement

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 2:24 AM EDT - 4 months ago

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 6, 2025, 4:05 PM EDT - 4 months ago

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

OmniAb to Report Second Quarter 2025 Financial Results on August 6

Jul 16, 2025, 8:00 AM EDT - 5 months ago

OmniAb to Report Second Quarter 2025 Financial Results on August 6

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025, 4:05 PM EDT - 7 months ago

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025, 3:52 AM EDT - 7 months ago

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 4:06 PM EDT - 7 months ago

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025, 4:05 PM EDT - 7 months ago

OmniAb Introduces the xPloration® Partner Access Program

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

May 5, 2025, 1:00 AM EDT - 7 months ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025, 8:00 AM EDT - 7 months ago

OmniAb to Participate in Five Upcoming Investor Conferences

OmniAb Announces Two New Appointments to its Board of Directors

Apr 21, 2025, 8:00 AM EDT - 8 months ago

OmniAb Announces Two New Appointments to its Board of Directors

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 9 months ago

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Mar 18, 2025, 4:05 PM EDT - 9 months ago

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

Feb 24, 2025, 8:00 AM EST - 10 months ago

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

OmniAb to Participate in Two Investor Conferences in March

Feb 3, 2025, 4:57 PM EST - 10 months ago

OmniAb to Participate in Two Investor Conferences in March

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

Jan 31, 2025, 11:09 AM EST - 11 months ago

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

Dec 16, 2024, 4:15 PM EST - 1 year ago

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 9:53 PM EST - 1 year ago

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 12, 2024, 4:05 PM EST - 1 year ago

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

OmniAb to Participate in Two Investor Conferences in November

Oct 30, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in November

OmniAb to Report Third Quarter 2024 Financial Results on November 12

Oct 22, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report Third Quarter 2024 Financial Results on November 12

OmniAb to Participate in Two Investor Conferences in September

Aug 26, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in September

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:28 AM EDT - 1 year ago

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 8, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

Aug 6, 2024, 8:25 AM EDT - 1 year ago

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

FIP FTAI IMVT PRPL REAL RICK

OmniAb to Report Second Quarter 2024 Financial Results on August 8

Jul 25, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report Second Quarter 2024 Financial Results on August 8

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

Jun 3, 2024, 4:05 PM EDT - 1 year ago

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

OmniAb to Participate in the Jefferies Global Healthcare Conference

May 20, 2024, 8:05 AM EDT - 1 year ago

OmniAb to Participate in the Jefferies Global Healthcare Conference

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

May 15, 2024, 4:05 PM EDT - 1 year ago

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

May 10, 2024, 4:33 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

May 9, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

OmniAb to Participate in Five Investor Conferences in May

May 1, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Investor Conferences in May

OmniAb to Report First Quarter 2024 Financial Results on May 9

Apr 22, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report First Quarter 2024 Financial Results on May 9

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

Apr 15, 2024, 8:31 AM EDT - 1 year ago

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

THAR

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 7:38 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 20, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

Feb 26, 2024, 8:00 AM EST - 1 year ago

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Dec 14, 2023, 4:30 PM EST - 2 years ago

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

Nov 14, 2023, 12:44 PM EST - 2 years ago

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

Nov 9, 2023, 5:55 PM EST - 2 years ago

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 9, 2023, 8:00 AM EST - 2 years ago

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

OmniAb Appoints Steve Love to its Board of Directors

Nov 1, 2023, 9:00 AM EDT - 2 years ago

OmniAb Appoints Steve Love to its Board of Directors

JoeDeMencia
JoeDeMencia Dec. 5 at 2:33 PM
$OABI is this another bull trap or does it have some legs finally?
0 · Reply
bearsoil
bearsoil Dec. 4 at 9:08 PM
$OABI nice trading at the close Great chart Good year ahead
0 · Reply
MrEsKurr
MrEsKurr Dec. 3 at 9:33 PM
$OABI im only it at 1.86 closing price .. this also looks great.
0 · Reply
PlannedTrading101
PlannedTrading101 Nov. 24 at 4:22 PM
$OABI Looking solid!
0 · Reply
stockanalysis_
stockanalysis_ Nov. 24 at 1:16 PM
Premarket Losers: $CLSD $TWNP $PMN $SHPH $OABI Bookmark this page: https://stockanalysis.com/markets/premarket/losers/?ref=saveontrading
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:39 PM
$OABI $OBIO $OCGN 🔥
0 · Reply
Landomos
Landomos Nov. 21 at 8:13 PM
$OABI Starting to gently edge up. $4:00 would not be far fetched soon.
0 · Reply
PlannedTrading101
PlannedTrading101 Nov. 21 at 5:45 PM
$OABI 2+ coming any day IMO
0 · Reply
PlannedTrading101
PlannedTrading101 Nov. 20 at 9:10 PM
$OABI Ready to run!
0 · Reply
Stockboi_
Stockboi_ Nov. 20 at 4:03 PM
$OABI we poppin
0 · Reply
Stockboi_
Stockboi_ Nov. 18 at 8:24 PM
$OABI double bottom on the hourly near POC
0 · Reply
tranq19
tranq19 Nov. 18 at 1:10 PM
$OABI what am I missing? Not seeing any negative news
0 · Reply
Mr_patience_MAN
Mr_patience_MAN Nov. 18 at 2:09 AM
$OABI why over nightis goinp down?😰 I'm in at 1.41😰😰 help😰
0 · Reply
Reesifer
Reesifer Nov. 18 at 12:58 AM
$OABI added 1.42
1 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Nov. 17 at 11:10 PM
$OABI and $ACHR both can be huge tomorrow
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Nov. 17 at 11:07 PM
$OABI 4.21 gap to fill. $54M cash. insiders loading. can be big tomorrow like $CLIK and $SGBX
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Nov. 17 at 11:00 PM
$OABI $4.21 gap to fill. $54M cash. insiders loading. can be big tomorrow like $SSP and $BNR
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Nov. 17 at 10:57 PM
$OABI insiders loading
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Nov. 17 at 10:53 PM
$OABI $3.X next. $54M cash. tomorrow can be big
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Nov. 17 at 10:46 PM
$OABI $54M cash. big news. ww tomorrow
0 · Reply
BearishAlgo
BearishAlgo Nov. 17 at 10:36 PM
$OABI I was waiting for it break $2 level where it has major resistance, but failed. No trade
0 · Reply
BearishAlgo
BearishAlgo Nov. 17 at 10:26 PM
$OABI watching
0 · Reply